Neurophth finishes GMP facility for gene therapy products

The 8,000 sqm gene therapy-focused current good manufacturing practice (cGMP) production facility includes two drug substance production suites according to international standards

picture of

Breaking News

PerkinElmer completes $5.25bn acquisition of antibody specialist

BioLegend has been acquired by PerkinElmer in the largest acquisition in the company's history

Mycenax builds first continuous bioprocessing lab in Taiwan

Cytiva has partnered with biopharma CDMO Mycenax Biotech to expand commercial manufacturing of its first biosimilar

Protagen Protein Services merges with GeneWerk

The move establishes a premier, protein and gene analytic testing service platform worldwide

Overcoming the bioprocessing challenges of personalised medicines

The pharmaceutical industry is facing major challenges to both its traditional business model and the development of ...

Repligen plans Polymem acquisition to expand hollow fibre capabilities

The CDMO has made the acquisition to significantly expands hollow fibre membrane and module production capabilities for ...

Thermo Fisher launches next-gen mass spectrometry solutions at summit

The new systems and software tools support scientists working across a wide range of applications, from proteomics ...

Deciding on a chemistry, manufacturing and control strategy for biologic development

Khanh Ngo Courtney from Avomeen discusses what biopharmaceutical companies should keep in mind as they embark on their ...

Avantor acquires RIM Bio to expand single-use business into China

Avantor has acquired a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical ...

Cell-based therapy specialist Solentim expands European operations

The England-based company has established a new EU entity based in Ireland to facilitate frictionless business within ...

Holding CAR-T cell therapies to a higher standard with ddPCR

Stringent quality control during manufacturing yields safer, more effective therapies, advise Mark White, Associate ...

Using ddPCR to accurately quantify AAV viral titre and integrity

Gene therapy is primed to become the next major development in medicine and bring relief to patients living with ...

Leveraging bioelectronic assays for cell-based therapy

Cell-based immunotherapies are revolutionising medicine; and, although they are relatively new, they are poised to ...

Catalent acquires third facility in Belgium for pDNA manufacturing

CDMO Catalent has acquired liver disease specialist Promethera's cell therapy manufacturing subsidiary, including its ...

German CDMO to spend $84m expanding biological cGMP space

Richter-Helm BioLogics has received investment for the new multi-product biological manufacturing facility that is ...